Patient-derived mutations impact pathogenicity of SARS-CoV-2

Summary The sudden outbreak of the severe acute respiratory syndrome–coronavirus (SARS-CoV-2) has spread globally with more than 1,300,000 patients diagnosed and a death toll of 70,000. Current genomic survey data suggest that single nucleotide variants (SNVs) are abundant. However, no mutation has been directly linked with functional changes in viral pathogenicity. We report functional characterizations of 11 patient-derived viral isolates. We observed diverse mutations in these viral isolates, including 6 different mutations in the spike glycoprotein (S protein), and 2 of which are different SNVs that led to the same missense mutation. Importantly, these viral isolates show significant variation in cytopathic effects and viral load, up to 270-fold differences, when infecting Vero-E6 cells. Therefore, we provide direct evidence that the SARS-CoV-2 has acquired mutations capable of substantially changing its pathogenicity..

Medienart:

Preprint

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

bioRxiv.org - (2024) vom: 23. Apr. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

Yao, Hangping [VerfasserIn]
Lu, Xiangyun [VerfasserIn]
Chen, Qiong [VerfasserIn]
Xu, Kaijin [VerfasserIn]
Chen, Yu [VerfasserIn]
Cheng, Linfang [VerfasserIn]
Liu, Fumin [VerfasserIn]
Wu, Zhigang [VerfasserIn]
Wu, Haibo [VerfasserIn]
Jin, Changzhong [VerfasserIn]
Zheng, Min [VerfasserIn]
Wu, Nanping [VerfasserIn]
Jiang, Chao [VerfasserIn]
Li, Lanjuan [VerfasserIn]

Links:

Volltext [lizenzpflichtig]
Volltext [kostenfrei]

Themen:

570
Biology

doi:

10.1101/2020.04.14.20060160

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI017598168